These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1330445)

  • 21. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K; Seya T; Ariga H; Nagasawa S
    J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The C1q receptor.
    Erdei A; Reid KB
    Mol Immunol; 1988 Nov; 25(11):1067-73. PubMed ID: 3265474
    [No Abstract]   [Full Text] [Related]  

  • 23. C1q receptor.
    Ghebrehiwet B
    Methods Enzymol; 1987; 150():558-78. PubMed ID: 3123878
    [No Abstract]   [Full Text] [Related]  

  • 24. FN-C1q and C1 INH C1r-C1s complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia.
    Hidvégi T; Ermolin GA; Efremov EE; Dikov MM; Kurmanova LV; Vnashenkova GV; Merkulova MV; Kókai M; Panya A; Füst G
    Immunol Lett; 1989 Jul; 22(1):1-6. PubMed ID: 2550362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microparticle generation during in vitro platelet activation by anti-CD9 murine monoclonal antibodies.
    Nomura S; Nagata H; Suzuki M; Kondo K; Ohga S; Kawakatsu T; Kido H; Fukuori T; Yamaguchi K; Iwata K
    Thromb Res; 1991 Jun; 62(5):429-39. PubMed ID: 1896962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The regulation of complement on cell surfaces.
    Devine DV
    Transfus Med Rev; 1991 Apr; 5(2):123-31. PubMed ID: 1726550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane-bound hemagglutinin mediates antibody and complement-dependent lysis of influenza virus-treated human platelets in autologous serum.
    Kazatchkine MD; Lambré CR; Kieffer N; Maillet F; Nurden AT
    J Clin Invest; 1984 Sep; 74(3):976-84. PubMed ID: 6470149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human blood platelet gC1qR/p33.
    Peerschke EI; Ghebrehiwet B
    Immunol Rev; 2001 Apr; 180():56-64. PubMed ID: 11414364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
    Matsumoto M; Sugita Y; Seya T
    Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.
    Ekdahl KN; Nilsson B
    J Immunol; 1999 Jun; 162(12):7426-33. PubMed ID: 10358196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis.
    Peerschke EI; Ghebrehiwet B
    Immunobiology; 1998 Aug; 199(2):239-49. PubMed ID: 9777409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells.
    Nielsen CH; Pedersen ML; Marquart HV; Prodinger WM; Leslie RG
    Eur J Immunol; 2002 May; 32(5):1359-67. PubMed ID: 11981823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor.
    Wiedmer T; Shattil SJ; Cunningham M; Sims PJ
    Biochemistry; 1990 Jan; 29(3):623-32. PubMed ID: 2159784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a surface protein of the rabbit blood platelet with high affinity for collagen.
    Lahav J
    Exp Cell Res; 1987 Feb; 168(2):447-56. PubMed ID: 3026823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1q induces a rapid up-regulation of P-selectin and modulates collagen- and collagen-related peptide-triggered activation in human platelets.
    Skoglund C; Wetterö J; Tengvall P; Bengtsson T
    Immunobiology; 2010 Dec; 215(12):987-95. PubMed ID: 20163886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Complement inhibition: a new therapeutic modality?].
    Porcel JM
    Med Clin (Barc); 1995 Nov; 105(18):700-2. PubMed ID: 8538252
    [No Abstract]   [Full Text] [Related]  

  • 37. Membrane inhibitor of reactive lysis.
    Holguin MH; Parker CJ
    Curr Top Microbiol Immunol; 1992; 178():61-85. PubMed ID: 1385046
    [No Abstract]   [Full Text] [Related]  

  • 38. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P; McRill CM; Ross SC
    J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials.
    Mollnes TE; Videm V; Riesenfeld J; Garred P; Svennevig JL; Fosse E; Hogasen K; Harboe M
    Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):21-6. PubMed ID: 1934602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of human platelets through gp140, the C3d/EBV receptor (CR2).
    Nunez D; Charriaut-Marlangue C; Barel M; Benveniste J; Frade R
    Eur J Immunol; 1987 Apr; 17(4):515-20. PubMed ID: 2952514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.